Innate Pharma calls extraordinary shareholder meeting for May 21

French biotech Innate Pharma is holding an extraordinary general meeting on May 21, 2026 to present resolutions to shareholders.

Published 9sem1 sourceNotableupdated 4j

≈ 22sSpeed

The fact

This meeting comes amid volatile stock valuation for the pharmaceutical research group.

The company will present specific documentation to shareholders to justify decisions submitted to vote.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 19, 2026